North America Apheresis Equipment Market to 2027 - Regional Analysis and Forecasts By Product; Technology; Procedure; Therapeutic Area; End User, and Country

The North America apheresis equipment market is expected to reach US$ 1,387.38 Mn in 2027 from US$ 755.36 Mn in 2018. The market is estimated to grow with a CAGR of 7.3% from 2019-2027.

The growth of the apheresis equipment market is primarily attributed to the increasing elderly population and the increasing incidence of hematologic diseases. However, complications associated with apheresis are likely to have a negative impact on market growth. On the other hand, growing medical tourism in Mexico is likely to have a positive impact on the growth of the North America apheresis equipment market in the coming years.

Apheresis is a process in which blood is temporarily removed from the donor’s body and separated into various components such as plasma, platelets, red blood cells as well as white blood cells. It is done by centrifugation or membrane separation process. Blood diseases affect one or more parts of the body as well as total health. There are various blood diseases caused by certain genes. Some of the common blood diseases include anemia, hemophilia, von Willebrand disease (VWD), blood cancers such as myeloma, leukemia-lymphoma and others. The rising number of these diseases demands the need for a blood transfusion which is expected to increase the requirement of apheresis equipment, thereby bolstering the growth of the market.

Anemia is known to be the common blood disorder, and according to the National Heart, Lung, and Blood Institute, it affects more than 3 million Americans. For instance, according to the Centers for Diseases Control and Prevention (2017), approx. 5,382 deaths were estimated due to the anemia incidences in the U.S. Two of the most common types of apheresis used for the removal of a harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, multiple sclerosis and others. Cytapheresis is a process that removes an excess number of blood cells and is used in the treatment of leukemia, polycythemia and thrombocythemia. Thus, the rising incidence of hematologic diseases is expected to foster the growth of the apheresis equipment market in the region over the coming years.

In 2018, the disposable apheresis kits segment held the largest market share of the apheresis equipment market, by product. The disposable apheresis kits segment is also expected to dominate its market share in 2027 as the disposable apheresis kits are used on a large scale while conducting the procedure. Since these kits are intended for single-use and the number of apheresis procedures has been increasing, the demand for the disposable apheresis kits segment is anticipated to grow at a considerable rate.

In 2018, the membrane separation held a largest market share of the apheresis equipment market, by technology. This segment is also expected to dominate the market in 2027. Moreover, the segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

In 2018, the plasmapheresis segment held a largest market share of the apheresis equipment market, by procedure. This segment is also expected to dominate the market in 2027 owing to the increasing applications of the procedure. However, the LDL-Apheresis segment is expected to grow at faster rate due to the technique is used for the treatment of other rare diseases such as familial hypercholesterolemia.

In 2018, the hospitals & clinics segment held a largest market share of the apheresis equipment market, by end user. This segment is also expected to dominate the market in 2027. Moreover, the similar segment is expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for apheresis equipment included in the report are, Canadian Association of Geographers (CAG), Centers for Disease Control and Prevention (CDC), National AIDS Control Organization (NACO), National Blood Transfusion Council (NBTC), Organization for Economic Co-operation and Development (OECD) and others.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America apheresis equipment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America apheresis equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.